Transurethral Resection of Prostate Completed Phase 4 Trials for Solifenacin (DB01591)

IndicationStatusPhase
DBCOND0060709 (Transurethral Resection of Prostate)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01747577Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate)Treatment